Insmed (INSM) Inventory (2018 - 2026)
Insmed's (INSM) quarterly Inventory came in at $132.9 million in Q1 2026, up 31.97% year-on-year from $100.7 million in Q1 2025, and up 0.64% quarter-over-quarter from $132.1 million in Q4 2025.
Insmed (INSM) Inventory (2018 - 2026) Analysis & Trends
Insmed's Inventory history runs 9 years deep, the most recent figure standing at $132.9 million for Q1 2026.
- On a quarterly basis, Inventory rose 31.97% year-over-year to $132.9 million in Q1 2026; TTM through Mar 2026 was $132.9 million, a 31.97% increase from a year earlier, with the FY2025 full-year figure at $132.1 million, up 33.97% from the prior year.
- Inventory climbed to $132.9 million in Q1 2026 per INSM's latest filing, from $132.1 million in the prior quarter.
- Across five years, Inventory topped out at $132.9 million in Q1 2026 and bottomed at $64.1 million in Q1 2022.
- The 5-year median for Inventory is $83.2 million (2023), against an average of $90.7 million.
- Across the five-year window, Inventory fell 1.74% in 2022 and jumped 33.97% in 2025, its largest moves.
- Year by year, Inventory stood at $69.9 million in 2022, then climbed by 19.06% to $83.2 million in 2023, then grew by 18.41% to $98.6 million in 2024, then soared by 33.97% to $132.1 million in 2025, then increased by 0.64% to $132.9 million in 2026.
- Per Business Quant, the three latest INSM Inventory figures stand at $132.9 million (Q1 2026), $132.1 million (Q4 2025), and $121.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 681.59 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn | 132.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.91 Mn |
| Dec 31, 2025 | 132.07 Mn |
| Sep 30, 2025 | 120.97 Mn |
| Jun 30, 2025 | 107.61 Mn |
| Mar 31, 2025 | 100.71 Mn |
| Dec 31, 2024 | 98.58 Mn |
| Sep 30, 2024 | 98.47 Mn |
| Jun 30, 2024 | 90.06 Mn |
| Mar 31, 2024 | 82.96 Mn |
| Dec 31, 2023 | 83.25 Mn |
| Sep 30, 2023 | 77.92 Mn |
| Jun 30, 2023 | 77.35 Mn |
| Mar 31, 2023 | 71.32 Mn |
| Dec 31, 2022 | 69.92 Mn |
| Sep 30, 2022 | 66.28 Mn |
| Jun 30, 2022 | 67.02 Mn |
| Mar 31, 2022 | 64.15 Mn |
| Dec 31, 2021 | 67.01 Mn |
| Sep 30, 2021 | 67.45 Mn |
| Jun 30, 2021 | 60.39 Mn |